Literature DB >> 19081148

PHACES syndrome: otolaryngic considerations in recognition and management.

Emily F Rudnick1, Eunice Y Chen, Scott C Manning, Jonathan A Perkins.   

Abstract

OBJECTIVES: To describe the otolaryngic manifestations of PHACES and evaluate current diagnostic and management principles for these patients.
METHODS: A retrospective review was performed within a tertiary children's hospital. Children with segmental facial hemangiomas of infancy and one extracutaneous manifestation comprising PHACES (posterior fossa malformation, arteriovenous malformations, cardiac/aortic defects, eye anomalies, and sternal defect) were identified. Otolaryngic problems were evaluated with physical examination, audiogram, swallow evaluation, polysomnography, and laryngoscopy. Extracutaneous manifestations were diagnosed using radiology, echocardiogram, and EEG. Treatment for cutaneous and airway hemangiomas included oral and intralesional steroids, CO(2) or pulse-dye laser, tracheotomy, and surgical excision. Management of extracutaneous problems was system-dependent.
RESULTS: Of 246 children with segmental facial hemangiomas of infancy evaluated since January 2000, 5 girls (2.0%) met diagnostic criteria for PHACES. Mean age at last follow-up was 2.6 years (range 0.4-5.8). Each child had one extracutaneous manifestation of aortic anomaly (2/5), sternal clefting (2/5), and brain malformation (1/5). Otolaryngic abnormalities included middle ear atelectasis (1/5), tympanic membrane hemangiomas with conductive hearing loss (3/5), skin and cartilage ulceration (2/5), dysphagia (4/5), and airway hemangiomas with stridor (3/5). Three children received oral steroids and required pulse-dye laser for cutaneous hemangiomas of infancy. One child underwent tracheotomy. Additional interventions included tympanostomy tubes and resection of nasal hemangioma.
CONCLUSIONS: Diagnosis of PHACES requires awareness of the association of facial hemangiomas of infancy with systemic and airway problems. Otolaryngology-related manifestations of PHACES are not commonly described, and management should be tailored to the individual patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19081148     DOI: 10.1016/j.ijporl.2008.10.018

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  5 in total

Review 1.  CT and MRI of congenital nasal lesions in syndromic conditions.

Authors:  Daniel T Ginat; Caroline D Robson
Journal:  Pediatr Radiol       Date:  2015-01-09

2.  Hearing loss in PHACE syndrome: clinical and radiologic findings.

Authors:  Mark D Mamlouk; Bree Zimmerman; Erin F Mathes; Kristina W Rosbe
Journal:  Childs Nerv Syst       Date:  2018-05-10       Impact factor: 1.475

3.  PHACES syndrome in association with airway hemangioma: First report from Saudi Arabia and literature review.

Authors:  Sami N Alsuwaidan
Journal:  Ann Thorac Med       Date:  2012-01       Impact factor: 2.219

Review 4.  PHACE syndrome: clinical manifestations, diagnostic criteria, and management.

Authors:  Anita Rotter; Luciana Paula Samorano; Maria Cecília Rivitti-Machado; Zilda Najjar Prado Oliveira; Bernardo Gontijo
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

5.  PHACE syndrome and hearing loss.

Authors:  José Fernando Polanski; Rodrigo de Oliveira Veras; Lucas Resende Lucinda; Vanessa Mazanek Santos
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.